Hiroshi Ishiba - Concepedia

Author

Hiroshi Ishiba

Kyoto Prefectural University of Medicine ORCID

Also Known As

HIROSHI ISHIBA, Hiroshi Ishiba, for the Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD)

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Kyoto Prefectural University of Medicine Nara City Hospital Saiseikai Suita Hospital Japanese Red Cross Society Kyoto Daini Hospital Aichi Medical University

About

Hiroshi Ishiba is an author at Kyoto Prefectural University of Medicine specializing in pathology, medicine, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	196
2	Health Sciences	4	4	167
3	Epidemiology	2	2	39
4	Public Health	1	1	29
5	Cell Biology	1	1	49

Hiroshi Ishiba

Publications

878

Citations

H-Index

Page 1

	Year	Citations
Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non‐alcoholic fatty liver disease and type 2 diabetes mellitus Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Hepatology Research	2016	89
Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease Yoshio Sumida, Kazuyuki Kanemasa, Shunsuke Imai, Journal of Gastroenterology Metabolic Associated SteatohepatitisHepatologyNonalcoholic Fatty Liver DiseaseBiliary TractLiver Physiology	2015	85
Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease Yoshio Sumida, Yoshikazu Yonei, Saiyu Tanaka, Hepatology Research	2014	82
Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Hepatology Research	2016	80
Effect of 12‐week dulaglutide therapy in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease and type 2 diabetes mellitus Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Hepatology Research	2016	79
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma Aya Takahashi, Michihisa Moriguchi, Yuya Seko, Anticancer Research	2019	65
Serum alanine aminotransferase predicts the histological course of non‐alcoholic steatohepatitis in <scp>J</scp>apanese patients Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Hepatology Research	2014	55
Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice Kota Yano, Kanji Yamaguchi, Yuya Seko, Laboratory Investigation InflammationMetabolic SyndromeObesityMetabolic Associated SteatohepatitisHigh-fat Diet-induced Obesity	2021	49
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes Hiroshi Ishiba, Yoshio Sumida, Yuya Seko, Hepatology Communications	2020	47
Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high‐fat diet fed mice Kanji Yamaguchi, Takeshi Nishimura, Hiroshi Ishiba, Liver International	2014	43

Page 1